Recent Press Releases

September 22nd, 2020 

Globe Newswire -  Bio Conscious Technologies Inc. (“Bio Conscious”), a Prevention-as-a-Service™ technology company using machine learning to predict and prevent complications from chronic diseases, is announcing that its latest study assessing the capabilities of its Diabits app, has just been published in the JMIR Academic Journal.

Past Press Releases

August 10th, 2020 

Health Tech Insider  - Shelter-in-place orders have created their share of problems for everyone, but in some cases, the consequences of the COVID-19 pandemic have had a positive effect. According to an analysis of recent data from Diabits, staying home this spring may have had a positive impact on the lives of diabetes patients.

August 10th, 2020 

mHealth Times - Diabits patients' average glucose values decreased and daily fluctuations throughout the week became less pronounced during the COVID-19 pandemic. 

August 4th, 2020 

Yahoo Finance - Following the lockdown in March, Diabits patients average glucose values decreased and daily fluctuations throughout the week became less pronounced.

June 10th, 2020 

The Journal of mHealth - Bio Conscious has completed an in-house study demonstrating that Diabits is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute predictions.

June 10th, 2020 

Cardio Vascular Business - Bio Conscious, a Vancouver-based healthcare technology company, shared the results of a new in-house study that found Diabits could make accurate predictions using simulated continuous glucose monitoring data. A total of 30 virtual patients were assessed, including some with mixed hypoglycemia awareness and others with impaired hypoglycemia awareness. This virtual cohort also had a mix of adult and pediatric patients.

June 9th, 2020 

Techcouver - Vancouver’s Bio Conscious Technologies has completed an in-house study demonstrating that Diabits is capable of predicting blood glucose levels 60 minutes into the future.

June 9th, 2020 

Medical Devices and Diagnostics Industry  (MDDI) - Bio Conscious has completed an in-house study demonstrating that its Diabits app is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute predictions.

June 9th, 2020 

BioSpace - Bio Conscious has completed an in-house study demonstrating that its Diabits app is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute prediction

June 9th, 2020 

Markets Insider - Bio Conscious has completed an in-house study demonstrating that its Diabits app is capable of predicting blood glucose levels 60 minutes into the future, an improvement on industry-leading continuous glucose monitoring companies that offer only 20-minute prediction

May 11th, 2020 

Bio Conscious launches Endobits, a physician platform that provides decision support for doctors by analyzing real-time patient data to identify and prioritize which patients are in urgent need of care and reduce unnecessary in-person appointments.

April 6th, 2020 

Bio Conscious Technologies Inc. published the results of the latest in-silico testing of their AI algorithm’s reliability using the FDA approved Padova simulator. 

November 14th, 2019 

innovateBC News - Diabits is our first product – it’s an app for people with Type 1 diabetes and those with Type 2 diabetes that are on insulin therapy. Diabits learns the user’s blood sugar fluctuations using machine learning and predicts instances of hypo and hyperglycemia (both of which can be life threatening) at least one hour in advance. 

April 26th, 2019 

Healthcare IT News - Physicians worldwide have generally positive attitudes towards the use of artificial intelligence in healthcare, according to a new survey of nearly 500 pathologists practicing in 54 countries.

April 24th, 2019 

Benzinga - Premier Health Group announced that it will be working with Bio Conscious Technologies to pilot an artificial intelligence (AI) powered remote patient monitoring tool. This tool will be integrated into Premier's Juno Electronic Medical Records (EMR) software and patient app. 

December 4th, 2018 

Healthline - We went ‘back to school’ in November for our first-ever DIABETESMINE UNIVERSITY program held at UC San Francisco Mission Bay.

Interested in the science behind our technology?